- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
Full sequencing of the BRCA1/2 genes, plus deletion/duplication analysis. May be used to assess the risk of carrying a BRCA1/2 mutation when there is no known familial mutation.
Targeted analysis of the founder mutations found within the Ashkenazi Jewish population. May be used as a first line test for individuals of Ashkenazi Jewish descent, if negative the option to run a Comprehensive BRCA1/2 Analysis is available.
Targeted sequencing for specific familial or known mutations on the BRCA1 gene.
Targeted sequencing for specific familial or known mutations on the BRCA2 gene.